# Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients

> **NCT07143513** · — · COMPLETED · sponsor: **Amgen** · enrollment: 102 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Sotorasib

## Key facts

- **NCT ID:** NCT07143513
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-11
- **Primary completion:** 2025-12-07
- **Final completion:** 2025-12-07
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07143513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07143513, "Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07143513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*